Real World Efficacy and Safety Outcomes Analysis of Upadacitinib in Acute Severe Ulcerative Colitis: A Propensity Score Matched Comparative Effectiveness Study Assessing Infliximab & Upadacitinib

被引：0
|
作者：
Khanna, Tushar [1 ]
Sehgal, Priya [1 ]
Desai, Aakash [2 ]
Mansoor, Emad [3 ]
Lichtenstein, Gary [1 ]
机构：
[1] Penn Med, Philadelphia, PA USA
[2] Mayo Clin, Jacksonville, FL USA
[3] Univ Hosp Cleveland Med Ctr, Digest Hlth Inst, Cleveland, OH USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001034916.67644.2a
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1387
引用
收藏
页码：S992 / S993
页数：2
相关论文
共 50 条
  • [41] Comparative effectiveness of vedolizumab and TNF-antagonist therapy in ulcerative colitis: a multicentre consortium propensity score-matched analysis
    Faleck, D.
    Shashi, P.
    Meserve, J.
    Rahal, M.
    Kadire, S.
    Tran, G.
    Weiss, A.
    Winters, A.
    Chablaney, S.
    Aniwan, S.
    Koliani-Pace, J. L.
    Kochhar, G.
    Boland, B.
    Singh, S.
    Hirten, R.
    Shmidt, E.
    Lasch, K.
    Luo, M.
    Bohm, M.
    Sagi, S. V.
    Fischer, M.
    Hudesman, D.
    Chang, S.
    Lukin, D.
    Sultan, K.
    Swaminath, A.
    Gupta, N.
    Siegel, C. A.
    Shen, B.
    Sandborn, W. J.
    Sands, B. E.
    Colombel, J-F.
    Kane, S.
    Loftus, E. V.
    Dulai, P. S.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S19 - S19
  • [42] INFLIXIMAB INDUCTION REGIMES IN STEROID REFRACTORY ACUTE SEVERE COLITIS: A MULTICENTRE COHORT STUDY WITH PROPENSITY SCORE ANALYSIS
    Sebastian, Shaji
    Myers, Sallyann
    Argyriou, Konstantinos
    Martin, Gayle
    Los, Louis
    Patel, Nischele C.
    Goodoory, Vivek
    Shaikh, FahadAli
    Fiske, Joseph
    Ranjan, Ravi
    Cooper, Benjamin E.
    Ching, Hey-Long
    Jayasooriya, NishaniLalanthika
    Brooks, Johanne
    Allen, Patrick B.
    Samuel, Sunil
    Moran, Gordon W.
    Dhar, Anjan
    Limdi, Jimmy K.
    Butterworth, Jeffrey
    Shenoy, Achuth
    Shenderey, Richard
    Parkes, Gareth C.
    Lobo, Alan J.
    Raine, Tim
    Subramanian, Sreedhar
    GASTROENTEROLOGY, 2019, 156 (06) : S646 - S646
  • [43] Effectiveness and safety of upadacitinib for moderate-to-severe atopic dermatitis in a real-world setting: A 52-week retrospective study
    Gargiulo, L.
    Ibba, L.
    Piscazzi, F.
    Alfano, A.
    Ingurgio, R. Cascio
    Valenti, M.
    Costanzo, A.
    Narcisi, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (02) : e152 - e154
  • [44] Assessing the efficacy of biologics in ulcerative colitis: A real-life, observational retrospective multicenter study using the propensity score analysis: The 'AURORA' comparison study
    Cassinotti, A.
    Mezzina, N.
    Di Paolo, D.
    Lenti, M. V.
    Bezzio, C.
    Stradella, D.
    Mauri, M.
    Zadro, V.
    Cortellezzi, C.
    Ricci, C.
    Casini, V.
    Radice, E.
    Massari, A.
    Ardizzone, S.
    Pastorelli, L.
    Di Sabatino, A.
    Manes, G.
    Caprioli, F.
    Vecchi, M.
    Tari, R.
    Occhipinti, P.
    Fichera, M.
    Invernizzi, P.
    Parravicini, M.
    Segato, S.
    Pace, F.
    Testoni, P. A.
    Tinelli, C.
    De Silvestri, A.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S477 - S478
  • [45] Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study
    Hagino, Teppei
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [46] INFLIXIMAB INDUCTION REGIMES IN STEROID REFRACTORY ACUTE SEVERE COLITIS: MULTI-CENTRE STUDY WITH PROPENSITY SCORE ANALYSIS
    Sebastian, Shaji
    Myers, Sally
    Subramanian, Sreedhar
    GUT, 2019, 68 : A65 - A66
  • [47] Comparative effectiveness of natalizumab versus ocrelizumab in multiple sclerosis: a real-world propensity score-matched study
    Pape, Katrin
    Rolfes, Leoni
    Steffen, Falk
    Muthuraman, Muthuraman
    Korsen, Melanie
    Meuth, Sven G. G.
    Zipp, Frauke
    Bittner, Stefan
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2022, 15
  • [48] Efficacy and safety of tofacitinib in patients with moderate-to-severe ulcerative colitis: A real-world retrospective study
    Yoshimura, N.
    Okano, Soh
    Sako, Minako
    Takazoe, Masakazu
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S545 - S545
  • [49] Comparison of accelerated and standard infliximab induction regimens in Acute Severe Ulcerative Colitis using propensity score: A retrospective multicenter study in a Chinese cohort
    Liu, X.
    Li, H.
    Tian, F.
    Xie, Y.
    Zhang, X.
    Zhi, M.
    Zhang, M.
    Song, X.
    Guo, H.
    Li, X.
    Liang, J.
    Shen, J.
    Li, Y.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1449 - I1450
  • [50] Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)
    Garcia, Maria Jose
    Riestra, Sabino
    Amiot, Aurelien
    Julsgaard, Mette
    Garcia de la Filia, Irene
    Calafat, Margalida
    Aguas, Mariam
    de la Pena, Luisa
    Roig, Cristina
    Caballol, Berta
    Casanova, Maria Jose
    Farkas, Klaudia
    Boysen, Trine
    Bujanda, Luis
    Cuaran, Camila
    Dobru, Daniela
    Fousekis, Fotios
    Gargallo-Puyuelo, Carla Jerusalen
    Savarino, Edoardo
    Calvet, Xavier
    Huguet, Jose Maria
    Kupcinskas, Limas
    Lopez-Cardona, Julia
    Raine, Tim
    van Oostrom, Joep
    Gisbert, Javier P.
    Chaparro, Maria
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (10) : 1248 - 1259
12345